Retinal and Choroidal Microvascular Changes During Pregnancy Period Detected With Optical Coherence Tomography Angiography

November 1, 2021 updated by: Çisil Erkan Pota, Akdeniz University

Evaluation of Retinal and Choroidal Microvascular Structures: Comparison With Three Trimesters of Healthy Pregnant Women and Healthy Non-pregnant Women Using Optical Coherence Tomography Angiography

During pregnancy many physiological changes and adaptations occur.Hormonal, hematological and hemodynamic changes are responsible for most of the ocular adaptations.We are planning to compare the choroid and retinal blood flow values and choroidal thickness of pregnant women and healthy non pregnant women with optical coherence tomography and optic coherence tomography angiography

Study Overview

Detailed Description

During pregnancy many physiological changes and adaptations occur such as pulmonary, renal, endocrinological, haematological and visual system changes are happening. In previous studies, retinal and choroidal pregnancy-related changes in blood flow and choroidal thickness have been demonstrated. Optical coherence tomography angiography (OCTA) detects the contrast of motion in the blood flow, detecting the capillary of the retina and choroid.

It is a new functional method that visualizes the retinal networks and outer retina without using dyes.It is a non-invasive method that provides volumetric angiography information. In this study evaluation of the variability of choroidal and retinal blood flow changes and choroidal thickness, between trimesters of pregnancy and the non-pregnant control group is planned. Choroid and Retinal Blood Flow Values and Choroidal thickness in 41 pregnant women in the first trimester and it would be repeated at second and third trimesters. We compare measured values between trimesters and 45 healthy non-pregnant women.

Study Type

Observational

Enrollment (Actual)

86

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antalya, Turkey, 07070
        • Akdeniz University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Retinal and choroid thickness and retinal angiographic values will be measured in healthy pregnant population (1 time for each trimester,totally 3 times) and healty control group

Description

Inclusion Criteria:

  • Healthy pregnant women Age > 18 years

Exclusion Criteria:

  • Systemical disease such as diabetes mellitus or hypertension
  • Refractive error; spherical equivalence > 4 diopters
  • Ocular disease or surgery history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pregnant Women
Healty pregnant women between 18-45 years,with no history of eye surgery and systemical disease.In 1st , 2nd and 3rd trimesters the measurements will be repeated
Optical coherence tomography optical coherence tomography angiography
Other Names:
  • Blood Pressure Measurement
  • Pachymetry
  • Otorefractometry
  • Tonometry
Control Group
Healty non-pregnant women between 18-45 years with no history of eye surgery and systemical disease.
Optical coherence tomography optical coherence tomography angiography
Other Names:
  • Blood Pressure Measurement
  • Pachymetry
  • Otorefractometry
  • Tonometry

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Choroidal thickness
Time Frame: 40 weeks
Choroidal thickness is measured by optical coherence tomography
40 weeks
Retinal thickness
Time Frame: 40 weeks
Retinal thickness is measured by optical coherence tomography
40 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foveal avascular zone(FAZ) area measurement
Time Frame: 40 weeks
FAZ area is measured by optical coherence tomography anjiography
40 weeks
Retinal vascular density
Time Frame: 40 weeks
% of retinal vascular density is measured by optical coherence tomography angiography
40 weeks
Retinal nerve fiber layer thickness
Time Frame: 40 weeks
Retinal nerve fiber layer thickness (um) is measured by optical coherence tomography
40 weeks
Ganglion cell layer measurement
Time Frame: 40 weeks
Ganglion cell layer measurement is measured by optical coherence tomography
40 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 26, 2021

Primary Completion (ACTUAL)

November 1, 2021

Study Completion (ACTUAL)

November 1, 2021

Study Registration Dates

First Submitted

June 24, 2021

First Submitted That Met QC Criteria

June 26, 2021

First Posted (ACTUAL)

July 6, 2021

Study Record Updates

Last Update Posted (ACTUAL)

November 2, 2021

Last Update Submitted That Met QC Criteria

November 1, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Study1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Optical Coherence Tomography,Optical Coherence Tomography Angiography(Topcon)

Subscribe